- - -









- - -
Investment opportunities

Tips from an insider: Five innovative tech startups

Tips from an insider: Stockholm tech start-ups

5 hot life science firms in Stockholm

Stockholm's top five infrastructure projects

Four Stockholm-based ICT firms to watch

Stockholm pioneers life science research

ICT startups offer investment opportunity

Swedish companies ready for exit

Five med-tech investment opportunities

Six cleantech investment opportunities

- - -
Rankings and surveys

Sweden tops English-language skills ranking

Sweden ranked world's best country to grow old

Swedish passport world's best for travellers

Sweden second best country for mothers

Stockholm climbs in competitiveness rankings

Sweden among best countries to be born

Fortune: 'Stockholm top place for startups'

Sweden tops first global Web Index

Sweden world's second most innovative country

Stockholm world's 6th 'best city'

'Cool Stockholm' most competitive Nordic capital

Sweden has (second) best reputation in the world

Sweden among top in Internet download speed

Sweden scores highest in 'Rule of law index'

Stockholm world's No1 in intellectual capital

Sweden the world's most ICT-competitive country

Sweden great place for moms – but Norway better

Swedes place 4th in English skills ranking

Sweden among top ICT countries

Sweden’s 10 greenest brands

‘Sweden needs to sell itself more’

Sweden overtakes the US in competitiveness

Sweden 10th ‘most admired country globally’

Sweden climbs in 'doing business' ranking

Sweden among world's least corrupt nations

Sweden's mortality rates world's second lowest

Sweden a good place to die – but Britain is best

Children in Sweden have best lives

Sweden the most competitive EU nation

Safe to do business with Swedes

How Sweden became an innovation frontrunner

Nordic countries world's most food-secure

Sweden the world’s best country – politically

Swedish firms among world's top brands

Swedish brands climb in global ranking

Sweden tops government ranking - while US lags 

'Swedish model' outranks 'American dream'  

Sweden among world's least corrupt nations

The Swedish Wire is a media production company that provides high-quality text, image and video content for international clients.

Orexo: Orexo plans buyback program of company shares

Press release published at The Swedish Wire

Uppsala - June 14, 2012 - On June 4, 2012 Orexo announced that an agreement was reached with ProStrakan Group plc regarding Abstral®, whereby Orexo acquired all rights for Abstral in the USA and restructured the existing royalty arrangements in both the EU and the rest of the world. In addition to future royalty and milestone payments, Orexo will receive a fixed net consideration of MGBP 55 (approximately MSEK 610), that will be paid during the coming 24 months.

With the strengthened balance sheet, Orexo sees the opportunity to change the capital structure and thus increase shareholder value through a buyback of company shares.

Orexo will therefore convene an Extraordinary General Meeting of shareholders in July, at which a resolution will be proposed authorizing the Board to purchase up to a maximum of ten percent of all outstanding shares in the market.

"The agreement with ProStrakan means Orexo's cash position has been considerably strengthened and the Company's financial risk reduced. With the Company's development programmes progressing well, the Board believe that the buyback of company shares will create shareholder value and is an appropriate use of capital.", says Martin Nicklasson, Chairman of the Board of Orexo.


For further information, please contact:
Anders Lundström, President & CEO
Tel: +46-706 67 22 66, Email: anders.lundstrom@orexo.com

Carl-Johan Blomberg, CFO
Tel: +46-706 33 67 11, Email: carl-johan.blomberg@orexo.com

About Orexo
Orexo AB is an emerging specialty pharma company developing improved treatments using proprietary drug delivery technology. Orexo's expertise is within the area of reformulation technologies and especially sublingual formulations.
Orexo has a portfolio of revenue generating EU and US approved products currently marketed under licence and a pipeline of several reformulations of approved compounds for areas of unmet medical need. Orexo also has collaboration projects with several international pharma companies.
Orexo AB is Swedish headquartered with 100 employees and listed on NASDAQ-OMX. The largest shareholders are Danish Novo A/S and Swedish HealthCap.
For information about Orexo please visit www.orexo.com

This is information that Orexo AB (publ) discloses pursuant to the Financial Instruments Trading Act and/or Securities Market Act. The information was provided for public release on June 14, 2012 at 08:00am CET. This press release has been prepared in both Swedish and English. In the event of any discrepancy in the content of the two versions, the Swedish version shall take precedence.

This information was distributed by Cision

Latest Jobs for English speakers in Sweden


Jobs for English speakers in Sweden

Most Read Searched